Thomas Hennessey

AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA.

Hopewell Therapeutics, Inc. is a company that is focused on discovering, synthesizing, and developing tissue-targeted lipid nanoparticles (TTLNPs) to bring genomic medicines to patients. The company is based in Woburn, MA and was founded in 2018 by Qiaobing Xu. Hopewell is pursuing opportunities to redefine the non-viral delivery space for novel genomic medicines by designing systemically administered LNPs to specifically target extrahepatic tissues and cells throughout the body. The company has built a robust intellectual property portfolio with an expansive library of ionizable lipids and has established partnerships with several industry-leading companies. Hopewell is developing its own internal pipeline, initially targeting diseases of the lung, while concurrently exploring the potential of its TTLNP platform for patients with unmet needs in oncology, infectious diseases, rare genetic diseases, and neurological disorders. Louis Brenner has been the CEO of the company since 2022.

Part of Applied Biosystems, Inc., Photovac, Inc. is a Canadian company that specializes in portable environmental instruments. The private company is based in Markham, Canada. Photovac was acquired by Applera Corp. on April 13, 1995.

PHT Corp. designs and develops software applications. The firm offers biopharmaceutical clients comprehensive services for acquiring, managing, and analyzing data collected directly from patients through all phases of clinical development. Its electronic clinical outcome assessment (eCOA) system collects and reports secure real-time patient data from smartphones, tablets, and the web. The company was founded by Stephen Raymond in 1994 and is headquartered in Boston, MA.

SonaMed Corp. designs, develops, manufactures and markets automated, internet ready screening and monitoring systems for the hospital, physician's office and home monitoring markets. The company was founded by William Ford Dolphin in 1994 and is headquartered in Waltham, MA.

AutoImmune, Inc. develop products to treat autoimmune and other cell-mediated inflammatory conditions. Its products are based on a biological mechanism known as oral tolerance, which provides tissue specific immunosuppression without toxicity or significant side effects. The company was founded in September 1988 and is headquartered in Pasadena, CA.